Difficulties Detecting Clinically Relevant Factor Xa Inhibitor Levels Prior to Reversal With Andexanet Alfa for Intracranial Hemorrhage.

Davis, Sarah Elizabeth B; Dehne, Kelly A; Rubinos, Clio A; Lau, Winnie K; Northam, Kalynn A

Davis, Sarah Elizabeth B; Dehne, Kelly A; Rubinos, Clio A; Lau, Winnie K; Northam, Kalynn A.

Afiliación

Davis SEB; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Dehne KA; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Rubinos CA; Department of Neurology, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Lau WK; Department of Neurology, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Northam KA; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.

Neurohospitalist ; 12(2): 276-279, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35419146

Palabras clave

factor Xa; factor Xa inhibitors; intracranial hemorrhages; partial thromboplastin time; prothrombin time

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurohospitalist Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google